 |
H-053740 |
(S)-(2-(4-chlorophenyl)pyrrolidin-1-yl)(3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone
CAS NO.：1883423-59-3 |
%2fC%3dC%2fC2%3dCC(OC)%3dC(OC)C(OC)%3dC2) |
H-053741 |
(E)-1-(piperidin-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
CAS NO.：188546-66-9 |
C%3dC2F)CC1)C(NC3%3dCN(C(C)(C)CNCC(C)(C)C)C%3dN3)%3dO.%5bH%5dBr.%5bH%5dBr) |
H-053742 |
Nirogacestat dihydrobromide
CAS NO.：1962925-29-6 |
 |
H-053743 |
tolebrutinib
CAS NO.：1971920-73-6 |
 |
H-053744 |
(E)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one
CAS NO.：20069-09-4 |
 |
H-053745 |
CPD3616
CAS NO.：2140807-05-0 |
 |
H-053746 |
LOXO-292
CAS NO.：2152628-33-4 |
%3dN2)C2%3dC1C3CC3)NC4%3dCC(Cl)%3dC(OC)N%3dC4) |
H-053747 |
1-(5-chloro-6-methoxypyridin-3-yl)-3-(7-cyclopropyl-2-methylthiazolo[5,4-b]pyridin-6-yl)urea
CAS NO.：2178989-09-6 |
N(C1%3dCC(Cl)%3dC(N2N%3dCC%3dN2)N%3dC1)C3%3dCN%3dC(SC(C)%3dN4)C4%3dC3N5CCOCC5) |
H-053748 |
1-(5-chloro-6-(2H-1,2,3-triazol-2-yl)pyridin-3-yl)-1-(2-methyl-7-morpholinothiazolo[5,4-b]pyridin-6-yl)urea
CAS NO.：2178989-63-2 |
 |
H-053749 |
BAY241696
CAS NO.：2242464-44-2 |
 |
H-053750 |
(R)-2-(1-(4-amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one
CAS NO.：2429889-62-1 |
 |
H-053751 |
ART558
CAS NO.：2603528-97-6 |
%3dC(OC)C(OC)%3dC2)%3dO)CCC3%3dC1C%3dCC%3dC3) |
H-053752 |
(E)-2-(3-(3,4,5-trimethoxyphenyl)acryloyl)-3,4-dihydroisoquinolin-1(2H)-one
CAS NO.：2639833-10-4 |
 |
H-053753 |
diphenyl ((6-methylpyridin-2-yl)(phenylamino)methyl)phosphonate
CAS NO.：614750-85-5 |
 |
H-053754 |
(E)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)piperidin-2-one
CAS NO.：82017-78-5 |
CCC2(NCC(N3%5bC%40H%5d(C%23N)C%5bC%40H%5d(F)C3)%3dO)CC1)OCC) |
H-053755 |
Bisegliptin
CAS NO.：862501-61-9 |
 |
H-053756 |
CX-3543
CAS NO.：865311-47-3 |
 |
H-053757 |
Lanifibranor
CAS NO.：927961-18-0 |
 |
H-053758 |
GSK-2018682
CAS NO.：1034688-30-6 |
 |
H-053759 |
TAK-071
CAS NO.：1820812-16-5 |
 |
H-053760 |
methyl 4-acetamido-5-iodo-2-methoxybenzoate
CAS NO.：201214-53-1 |
